APA (7th ed.) Citation

Omar, A. M., Abdulmalik, O., El‐Say, K. M., Ghatge, M. S., Cyril‐Olutayo, M., Paredes, S., . . . Safo, M. K. (2024). Targeted modification of furan‐2‐carboxaldehydes into Michael acceptor analogs yielded long‐acting hemoglobin modulators with dual antisickling activities. Chemical Biology & Drug Design, 103(1), 1. https://doi.org/10.1111/cbdd.14371

Chicago Style (17th ed.) Citation

Omar, Abdelsattar M., Osheiza Abdulmalik, Khalid M. El‐Say, Mohini S. Ghatge, Mojisola Cyril‐Olutayo, Steven Paredes, Mohammed Al‐Awadh, Moustafa E. El‐Araby, and Martin K. Safo. "Targeted Modification of Furan‐2‐carboxaldehydes into Michael Acceptor Analogs Yielded Long‐acting Hemoglobin Modulators with Dual Antisickling Activities." Chemical Biology & Drug Design 103, no. 1 (2024): 1. https://doi.org/10.1111/cbdd.14371.

MLA (9th ed.) Citation

Omar, Abdelsattar M., et al. "Targeted Modification of Furan‐2‐carboxaldehydes into Michael Acceptor Analogs Yielded Long‐acting Hemoglobin Modulators with Dual Antisickling Activities." Chemical Biology & Drug Design, vol. 103, no. 1, 2024, p. 1, https://doi.org/10.1111/cbdd.14371.